glp-1 and kidney disease the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 Medications & Their Potential
Description
Two clinical studies show 200%+ GLP-1 increase & up to 25 lbs lost in 12 weeks
This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.
The intestine has garnered attention as a target organ for developing new therapies for impaired glucose tolerance
Indias pharma industry is strong
95% CI 0.35, 3.14)
